NCT04310046View on ClinicalTrials.gov

Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

986

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2031

Conditions
Aortic StenosisCoronary Artery DiseaseTAVIPCI
Interventions
PROCEDURE

PCI before TAVI

TAVI is performed using the Edwards SAPIEN Transcatheter Heart Valve®. PCI is performed in any suitable lesion with ≥70% diameter stenosis on coronary angiography in a coronary artery ≥2.5 mm in diameter.

PROCEDURE

PCI after TAVI

TAVI is performed using the Edwards SAPIEN Transcatheter Heart Valve®. PCI is performed in any suitable lesion with ≥70% diameter stenosis on coronary angiography in a coronary artery ≥2.5 mm in diameter.

Trial Locations (1)

8091

University Hospital Zürich, Cardiology Department, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER